...Inc. (NASDAQ:IDYA) announced a partnership covering three preclinical programs targeting the biosynthetic enzyme MAT2A, the DNA polymerase... ...1 early onset MAT2A - Methionine adenosyltransferase 2A PARP - Poly(ADP-ribose) polymerase POLQ - DNA-directed DNA polymerase...
...tests for the approach. The companies are developing different strategies to coax TDT, a template-independent DNA polymerase... ...to each oligo. Among companies developing enzyme technologies, the primary workhorse is TDT, a template-independent DNA polymerase...
...Bacteroides numbers. The company will present detailed trial data for the first-in-class antibiotic, a bacterial DNA polymerase... ...Feb. 26, 2020, respectively.
Sandi Wong, Staff Writer
Acurx Pharmaceuticals LLC
Esperion Therapeutics Inc.
Bacterial DNA polymerase...
...Lynparza olaparib. KuDos was acquired by AstraZeneca plc in 2005. Artios’ lead program targets DNA-directed DNA polymerase... ...University
Repare Therapeutics Inc.
Tango Therapeutics Inc.
Breast cancer 1 early onset (BRCA1)
Breast cancer 2 early onset (BRCA2)
DNA-directed DNA polymerase...